Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines

Nutrition and Cancer

Volumn 32, Issue 1, 1998, Pages 1-7

  Bardon, Sylvie ^a   Picard, Karine ^b   Martel, Paule ^a  

^a CEMAGREF   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESSENTIAL OIL; LIMONENE; MESSENGER RNA; PERILLYL ALCOHOL; TERPENE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FRUIT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; REGULATOR GENE; VEGETABLE;

EID: 0031742724     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514708     Document Type: Article

References (23)

1. Kelloff, GJ, Boone, CW, Crowell, JA, Steels, VE, Lubet, RA, et al.: New agents for cancer chemoprevention. J Cell Biochem 26S, 1-28, 1996.
2. Crowell, PL, and Gould, MN: Chemoprevention and therapy of cancer by d-limonene. Crit Rev Oncog 5, 1-22, 1994.
3. Wattenberg, LW, and Coccia, JB: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by d-limonene and citrus fruit oils. Carcinogenesis 12, 115-117, 1991.
4. Stark, MJ, Burke, YD, McKinzie, JH, Ayoubi, AS, and Crowell, PL: Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett 96, 15-21, 1995.
5. Reddy, BS, Wang, CX, Samaha, H, Lubet, R, Steele, VE, et al.: Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57, 420-425, 1997.
6. Haag, JD, Lindstrom, MJ, and Gould, MN: Limonene-induced regression of mammary carcinomas. Cancer Res 52, 4021-4026, 1992.
7. Haag, JD, and Gould, MN: Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34, 477-483, 1994.
8. McNamee, D: Limonene trial in cancer. Lancet 342, 801, 1993.
9. Gould, MN: Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect Suppl 105, 977-979, 1997.
10. Crowell, PL, Ren, Z, Lin, S, Vedejs, E, and Gould, MN: Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 47, 1405-1415, 1994.
11. Karlson, J, Borg-Karlson, AK, Unelius, R, Shoshan, MC, Wilking, N, et al.: Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a ras-independent mechanism of action. Anticancer Drug 7, 422-429, 1996.
12. Gillett, C, Fantl, V, Smith, R, Fisher, C, Bartek, J, et al.: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemistry staining. Cancer Res 54, 1812-1817, 1994.
13. Hinds, PW, Dowdy, SF, Eaton, EN, Arnold, A, and Weinberg, RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91, 709-713, 1994.
14. Goppelt-Stuebe, M, and Golombek, M: Fluorometric determination of the DNA content of cells cultured in tissue culture plates. J Immunol Methods 151, 245-248, 1992.
15. Chomczynski, P, and Sacchi, N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159, 1987.
16. Xyong, Y, Connoly, T, Futcher, B, and Beach, D: Human D-type cyclin. Cell 65, 691-699, 1991.
17. Sutherland, RL, Hamilton, JA, Sweeney, KJ, Watts, CK, and Musgrove, EA: Expression and regulation of cyclin genes in breast cancer. Acta Oncol 34, 651-656, 1995.
18. Maltzman, TH, Christou, M, Gould, MN, and Jefcoate, CR: Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes. Carcinogenesis 12, 2081-2087, 1991.
19. 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res 53, 3849-3852, 1993.
20. Ariazi, EA, and Gould, MN: Identifying differential gene expression in monoterpene-treated mammary carcinomas using substractive display. J Biol Chem 271, 29286-29294, 1996.
21. Crowell, PL, Chang, RR, Ren, Z, Elson, CE, and Gould, MN: Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266, 17679-17685, 1991.
22. Musgrove, EA, Hamilton, JA, Lee, CSL, Sweeney KJE, Watts, CKW, et al.: Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13, 3577-3587, 1993.
23. Bardon, S, and Razanamahefa, L: Retinoic acid suppresses insulin-induced cell growth and cyclin D1 gene expression in human breast cancer cells. Int J Oncol 12, 355-359, 1998.